Abstract
Resveratrol exerts functions relating apoptosis and differentiation; nonetheless, the mechanisms remain unclear. We examined the regulation of resveratrol on apoptosis and erythrocytic (E)-differentiation in leukaemia cells. The results showed that resveratrol treatment for 24h induced apoptosis in human leukaemia NB4, HL-60, and U937 cells. Resveratrol-treated K562 cells underwent erythrocyte (E)-differentiation and cell cycle arrest in S-phase, without apoptotic induction in the early stage, but with marked apoptosis in the later stages. Resveratrol-induced apoptosis could be accompanied by P38 downregulation, and E-differentiation could occur with PI3K/Akt upregulation. Downstream NF-κB was increased by resveratrol treatment for 24h, while luciferase activity was decreased by resveratrol treatment for 72h. Similar changes were discovered for nuclear levels and NF-κB-DNA binding activity. In conclusion, resveratrol induced differential responses through different signalling pathways, including PI3K/Akt and P38/MAPK, leading to opposing expressions of NF-κB. NF-κB could be a switch for regulating E-differentiation and apoptosis in resveratrol-stimulated K562 cells.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
